Cardiology Plus : Impact Factor & More
eISSN: 2470-752XpISSN: 2470-7511
Open AccessShare this on:
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Cardiology Plus
Cardiology Plus Journal Specifications
Indexed in the following public directories
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | Wolters Kluwer Health/LWW |
| Language | English |
| Publication Time | 20 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Publication Details | |
| Plagiarism | Visit website |
| Publication Time | 20 |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC-ND |
| OA statement | Visit website |
View less
Planning to publish in Cardiology Plus ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Cardiology Plus
Chinese expert consensus on percutaneous renal denervation therapy for hypertension (2025)
- 11 Mar 2026
- Cardiology Plus
Development and validation of a risk prediction model for left atrial appendage thrombus in patients with non-valvular atrial fibrillation
- 11 Mar 2026
- Cardiology Plus
Bridging traditions and evidence: Qiliqiangxin in the evolving landscape of heart failure therapy
- 2 Mar 2026
- Cardiology Plus
Safety and performance of the Micra VR leadless pacemaker in Chinese patients: a post-market, prospective, observational, non-randomized study
- 2 Mar 2026
- Cardiology Plus
Efficacy and safety of Qiliqiangxin capsule for heart failure with reduced ejection fraction: a systematic review and meta-analysis
- 2 Mar 2026
- Cardiology Plus
Single-cell sequencing and machine learning identify endoplasmic reticulum stress as a mechanism and therapeutic target in heart failure
- 2 Mar 2026
- Cardiology Plus
Chinese expert consensus on percutaneous renal denervation therapy for hypertension (2025)
- 11 Mar 2026
- Cardiology Plus
Development and validation of a risk prediction model for left atrial appendage thrombus in patients with non-valvular atrial fibrillation
- 11 Mar 2026
- Cardiology Plus
Bridging traditions and evidence: Qiliqiangxin in the evolving landscape of heart failure therapy
- 2 Mar 2026
- Cardiology Plus
Safety and performance of the Micra VR leadless pacemaker in Chinese patients: a post-market, prospective, observational, non-randomized study
- 2 Mar 2026
- Cardiology Plus
Efficacy and safety of Qiliqiangxin capsule for heart failure with reduced ejection fraction: a systematic review and meta-analysis
- 2 Mar 2026
- Cardiology Plus
Single-cell sequencing and machine learning identify endoplasmic reticulum stress as a mechanism and therapeutic target in heart failure
- 2 Mar 2026
- Cardiology Plus
FAQs on Cardiology Plus
How many articles did Cardiology Plus publish last year? 
What is the eISSN & pISSN for Cardiology Plus?
Who is the publisher of Cardiology Plus?
